New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Rakesh Amin and William J. Hallihan Announce Formation of Amin Hallihan LLC

Health industry legal experts team up to form 10-member group of FDA/FTC and
patent attorneys.

(Chicago) March 5, 2007 – Rakesh Amin, former managing member of Amin Law and William J. (Hal) Hallihan, previously head of Hallihan Intellectual Property Law Ltd., have announced the formation of Amin Hallihan LLC, the only full-service FDA, FTC and patent boutique law firm serving clients worldwide. Based in Chicago, Amin Hallihan is a 10-attorney group with over 100 years of combined FDA and patent experience.

Rakesh Amin, managing attorney, spends significant time practicing all aspects of FDA, FTC and USDA law as well as intellectual property law and litigation. His practice includes reviewing for regulatory compliance all forms of labeling, packaging and advertising including websites, radio shows, infomercials and third-party literature. His practice includes legal counsel concerning GRAS affirmations and notifications and New Dietary Ingredient/NDI submissions as well as for drug submissions such as FDA 2656 and 2657 submissions for homeopathic and OTC drug monograph products. He also helps companies respond to warning letters, FDA 483s and import detentions. Amin also helps clients protect, procure and license patents, trademarks, copyrights and trade secrets. He litigates patent and trademark infringement matters in federal courts throughout the country, including in California, New York, New Jersey, Texas, Florida, Delaware, Pennsylvania, Massachusetts, Colorado, Ohio, Michigan, Utah, Nevada and The District of Columbia. Amin has spearheaded over 25 federal patent and trademark infringement cases on behalf of clients nationwide for both plaintiffs and defendants and also practices in contracts and business litigation.
Amin is a registered pharmacist and Juris Doctor graduate of the John Marshall Law School in Chicago, Illinois. He earned a Masters in Laws in Health Law at the DePaul University College of Law, Health Law Institute and was editor of the DePaul Journal of Health Care Law. Amin has also taught Food and Drug Law as an adjunct professor at the DePaul University College of Law.

William J. (Hal) Hallihan is the manager of the Intellectual Property Practice Group. He is a registered patent attorney in the U.S. and Canada. His practice is focused on intellectual property procurement, licensing and litigation. Hallihan’s experience includes client counseling, technology transfer, patent and trademark prosecution, patent interference, patent re-examination, patent re-issue, due diligence, licensing and litigation. In addition, his expertise includes copyrights, trade secrets, antitrust, unfair competition, RICO actions and UCC issues. Hallihan has authored several articles on various intellectual property topics and also made presentations on a variety of intellectual property topics.

“Amin Hallihan understands the regulatory and patent complexities of food, dietary supplement, drug, cosmetic, pharmacy and medical device business,” says Amin. “Our group offers the expertise and experience to preserve the integrity and maximize the efficiencies and profitability of our clients.”

The firm specializes in FDA, FTC, U.S. Customs, USDA and DEA compliance including food, dietary supplement, drug, animal feed and cosmetic labeling, claims and third party literature reviews; advertising and substantiation reviews for print ads, websites, radio shows and infomercials; GRAS self-affirmations and GRAS notifications; New Dietary Ingredient/NDI submissions and Old Dietary Ingredient/ODI opinion letters; drug submissions including NDAs, ANDAs and INDs; 2656 Drug Facility Establishment and 2657 Drug Product Listing/NDC submissions for homeopathic and OTC drug monograph products; warning letter, FDA 483 responses and FDA/customs detention matters; Federal and State litigation involving alleged patent, trademark, copyright and trade secret infringement and counterfeiting; FDA and FTC violations; false advertising; unfair competition; breach of contract and Prop 65 violations; and licensing, joint venture, supplier, manufacturer, distributor and media-related agreements.

For more information about Amin Hallihan legal services, visit or contact Rakesh Amin at 312.466.1033.

# # # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.